We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
Email registered. Please sign in.×
Enter your contact to build trust with supplier(s)×
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Nanjing Kinglion Pharmachem. Co., Ltd. was established in year of 2005, located in Pukou Tangquan Industrial development Zone of Nanjing city. Our main products of API include Dexibuprofen DC grade, Tranexamic Acid, Nicorandil, Captopril and Cimetidine, etc. At the same time, we are supported by experienced specialists in organic chemistry, pharmaceutical chemistry and process optimization. Since inception, the enterprise has developed more than 10 new API products and their intermediates, including a few-Alibendol & Intermediates, Clopidogrel & Intermediates, Fluconazole & Intermediates, etc., which have been commercialized and exported to EU and South-East Asia. We have established R&D center and production area located in Pukou Tangquan Industrial development Zone of Nanjing city. Our company has its own self-management right of import & export and also owns a member of diligent, conscientious and high quality marketing staffs. We are specialized in selling our Group´s product
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Contract Manufacturing,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type: Manufacturer
R&D capacity:
Annual Turnover(USD): choose not to disclose
Main Sales Markets: North America,Western Europe,Asia
Nine years of qualification
Audited Supplier
![[5-(1-Hydroxyl-1-methylethyl)-2-propyl-imidazol-4-yl]carboxylic acid ethyl ester Basic information,(](https://eimg.pharmasources.com/img_Cphi_en/Products/2011_02/Pr_110201102345586A.jpg!280)
![1H-benzimidazole-7-carboxylicacid,1-[(2’-cyano-[1,1’-biphenyl]-4-yl)methyl]-2-ethoxy-,ethyl ester(13](https://eimg.pharmasources.com/img_Cphi_en/Products/2011_02/Pr_1102011026B6E93F.jpg!280)
![1-[2-Amino-1-(4- Methoxyphenyl) ethyl] Cyclohexanol.HCI intermediates](https://eimg.pharmasources.com/img_Cphi_en/Products/2011_02/Pr_1102011025D8C2FB.jpg!280)
Pharma Sources Insight June 2024: Globalization on the Go
